Director of Immunoassays (Site Head)
TGR BioSciences Pty Ltd (Abcam Company), Australia
A commercially minded biotechnology scientist with over 15 years industry experience in the development/commercialization of immunoassay screening technologies/products for academics, pharma/biotech's and diagnostics. Founder of TGR’s CaptSure immunoassay technology (formal IP) which underpins TGR’s internal R&D/Manufacturing activities and external commercialization activities. Lead the team in South Australia and its ongoing investment in the AlphaLISA SureFire Ultra platform for measurement of high value drug targets (kinases) for pharma/biotech drug discovery programs. Manage the commercialization/licensing opportunities linked to TGR’s core IP and its various industry collaborations.